Prominent international researchers have shown the AREDS2 formula, using the antioxidants lutein and zeaxanthin instead of beta-carotene supplements, not only...
Read moreA revolutionary new therapy for cataract has shown positive results in laboratory tests, giving hope the condition could soon be...
Read moreOne in 150 Australians have retinal scars caused by the Toxoplasma parasite, according a new Flinders University analysis that has...
Read moreA pioneering study out of Western Australia has shown that a longer acting intravitreal dexamethasone implant (DEX-implant) may lead to...
Read moreA survey of more than 500 Australian parents of children who see eyecare professionals has revealed the biggest barriers to...
Read moreGlaukos has commenced a Phase 2 clinical program for its third-generation iLink therapy designed to treat keratoconus. The ophthalmic medical...
Read moreAustralian engineers have invented a surgical smart glove built with low-cost sensors that can record hand movements in fine detail,...
Read moreAbout 5000 people are expected to participate in Australia’s first national survey combining ear and eye health, launched on 3...
Read moreDropout, hygiene compliance and other issues associated with contact lens wear will be the focus of a new study by...
Read moreData from patients with a subtype of AMD enrolled in Opthea’s Phase 2b clinical trial of OPT-302 in combination with...
Read moreInsight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.
© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited